BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12522438)

  • 1. Selectively replicating viral vectors.
    Nemunaitis J; Edelman J
    Cancer Gene Ther; 2002 Dec; 9(12):987-1000. PubMed ID: 12522438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oncolytic viruses for genetic therapy of gastrointestinal tumors].
    Bitzer M; Lauer UM
    Z Gastroenterol; 2003 Jul; 41(7):667-74. PubMed ID: 12858239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant vaccinia viruses as new live vaccines.
    Smith GL; Mackett M; Moss B
    Biotechnol Genet Eng Rev; 1984; 2():383-407. PubMed ID: 6100668
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis.
    Willems FT; Melnick JL; Rawls WE
    Proc Soc Exp Biol Med; 1969 Feb; 130(2):652-61. PubMed ID: 4303851
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral oncolysis.
    Donahue JM; Mullen JT; Tanabe KK
    Surg Oncol Clin N Am; 2002 Jul; 11(3):661-80. PubMed ID: 12487061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical development directions in oncolytic viral therapy.
    Eager RM; Nemunaitis J
    Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vector systems for gene therapy.
    Jolly D
    Cancer Gene Ther; 1994 Mar; 1(1):51-64. PubMed ID: 7621239
    [No Abstract]   [Full Text] [Related]  

  • 8. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.
    Moss B
    Dev Biol Stand; 1994; 82():55-63. PubMed ID: 7958483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brain tumor therapy using replication--competent virus vectors].
    Todo T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():504-9. PubMed ID: 16201572
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncolytic viruses and cancer therapy.
    Norman KL; Farassati F; Lee PW
    Cytokine Growth Factor Rev; 2001; 12(2-3):271-82. PubMed ID: 11325607
    [No Abstract]   [Full Text] [Related]  

  • 11. Virus susceptibility of marmoset kidney cell cultures.
    Schur VA; Holmes AW
    Proc Soc Exp Biol Med; 1965; 119(4):950-2. PubMed ID: 4284315
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of replication-defective West Nile virus vector to non-flavivirus vaccine targets.
    Giel-Moloney M; Vaine M; Zhang L; Parrington M; Gajewska B; Vogel TU; Pougatcheva SO; Duan X; Farrell T; Ustyugova I; Phogat S; Kleanthous H; Pugachev KV
    Hum Vaccin Immunother; 2017 Dec; 13(12):2982-2986. PubMed ID: 28925795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.
    Nakaya Y; Nakaya T; Park MS; Cros J; Imanishi J; Palese P; GarcĂ­a-Sastre A
    J Virol; 2004 Sep; 78(17):9366-75. PubMed ID: 15308731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vectors as influenza vaccines.
    Kopecky-Bromberg SA; Palese P
    Curr Top Microbiol Immunol; 2009; 333():243-67. PubMed ID: 19768410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication-selective viruses for cancer therapy.
    Biederer C; Ries S; Brandts CH; McCormick F
    J Mol Med (Berl); 2002 Mar; 80(3):163-75. PubMed ID: 11894142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital and neonatal anomalies linked with viral infections in experimental animals.
    Elizan TS; Fabiyi A
    Am J Obstet Gynecol; 1970 Jan; 106(1):147-65. PubMed ID: 4312333
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccinia virus recombinants as potential herpes simplex virus vaccines.
    Rooney JF; Wohlenberg CR; Notkins AL
    Adv Exp Med Biol; 1992; 327():183-9. PubMed ID: 1338264
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological characteristics and viral spectrum of serially cultivated fetal rhesus monkey kidney cells.
    Forman ML; Inhorn SL; Sheaff E; Cherry JD
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):1060-7. PubMed ID: 4307233
    [No Abstract]   [Full Text] [Related]  

  • 19. Reverse Genetics for Newcastle Disease Virus as a Vaccine Vector.
    Kim SH; Samal SK
    Curr Protoc Microbiol; 2018 Feb; 48():18.5.1-18.5.12. PubMed ID: 29512119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective replicating viral vectors : potential for use in cancer gene therapy.
    Nemunaitis J
    BioDrugs; 2003; 17(4):251-62. PubMed ID: 12899642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.